CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Option exercise · Stock Option (right to buy | −14,553 | 63,447 | ||
| 2023-04-03 | Lian Brian President & CEO | Sale | −22,000 | $17.85 | $393K | 2,232,963 |
| 2023-04-03 | Lian Brian President & CEO | Grant or award | +300,000 | 2,532,963 | ||
| 2023-04-03 | Lian Brian President & CEO | Shares withheld for taxes | −200,000 | $17.57 | $3.5M | 2,332,963 |
| 2023-04-03 | ZANTE GREG Chief Financial Officer | Option exercise | +30,911 | $7.77 | $240K | 178,689 |
| 2023-04-03 | ZANTE GREG Chief Financial Officer | Sale | −30,911 | $18.00 | $556K | 147,778 |
| 2023-04-03 | ZANTE GREG Chief Financial Officer | Grant or award | +56,667 | 204,445 | ||
| 2023-04-03 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −55,166 | $17.57 | $969K | 149,279 |
| 2023-04-03 | ZANTE GREG Chief Financial Officer | Option exercise · Stock Option (right to buy) | −30,911 | 0 | ||
| 2023-03-31 | Lian Brian President & CEO | Option exercise | +67,970 | $9.49 | $645K | 2,322,933 |
| 2023-03-31 | Lian Brian President & CEO | Sale | −67,970 | $17.45 | $1.2M | 2,254,963 |
| 2023-03-31 | Lian Brian President & CEO | Option exercise · Stock Option (Right to Buy) | −67,970 | 0 | ||
| 2023-03-30 | Lian Brian President & CEO | Option exercise | +115,852 | $1.23 | $142K | 2,388,815 |
| 2023-03-30 | Lian Brian President & CEO | Option exercise | +19,530 | $9.49 | $185K | 2,408,345 |
| 2023-03-30 | Lian Brian President & CEO | Sale | −88,000 | $16.95 | $1.5M | 2,320,345 |
| 2023-03-30 | Lian Brian President & CEO | Sale | −65,382 | $17.45 | $1.1M | 2,254,963 |
| 2023-03-30 | Lian Brian President & CEO | Option exercise · Stock Option (Right to Buy) | −115,852 | 134,148 | ||
| 2023-03-30 | Lian Brian President & CEO | Option exercise · Stock Option (Right to Buy) | −19,530 | 67,970 | ||
| 2023-03-30 | ZANTE GREG Chief Financial Officer | Option exercise | +32,000 | $8.52 | $273K | 217,057 |
| 2023-03-30 | ZANTE GREG Chief Financial Officer | Option exercise | +42,000 | $7.69 | $323K | 259,057 |
Page 15 of 27 · 528 trades